Coherus Oncology (CHRS) Research & Development (2013 - 2026)
Coherus Oncology (CHRS) reported Research & Development of $21.44 million for Q2 2026, down 18.5% from $26.31 million a year earlier and down 0.5% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Research & Development (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Coherus Oncology's Research & Development came in at $101.21 million, up 8.3% year-over-year; for FY2025, it was $108.89 million, up 18.6% from FY2024.
- Research & Development has a five-year compound annual growth rate of -5.3% (FY2020 to FY2025).
- By year, Research & Development came in at $91.83 million in FY2024 (-16.1%), $109.44 million in FY2023 (-45.1%), $199.36 million in FY2022 (-45.1%) and $363.11 million in FY2021 (+154.3%).
- The Q2 2026 figure ranks as the lowest quarterly Research & Development since Q4 2024.
- Year over year, Research & Development gained in three of the last eight quarters, with growth averaging 2.6%.
- The high point for year-over-year Research & Development in five years was Q4 2025 (growth of 49.2%); the low point was Q1 2022 (a decline of 59.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $21.54 million (Q1 2026), $30.97 million (Q4 2025) and $27.25 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | 21.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.44 Mn |
| Mar 31, 2026 | 21.54 Mn |
| Dec 31, 2025 | 30.97 Mn |
| Sep 30, 2025 | 27.25 Mn |
| Jun 30, 2025 | 26.31 Mn |
| Mar 31, 2025 | 24.36 Mn |
| Dec 31, 2024 | 20.76 Mn |
| Sep 30, 2024 | 22.05 Mn |
| Jun 30, 2024 | 20.60 Mn |
| Mar 31, 2024 | 28.42 Mn |
| Dec 31, 2023 | 26.37 Mn |
| Sep 30, 2023 | 25.65 Mn |
| Jun 30, 2023 | 23.27 Mn |
| Mar 31, 2023 | 34.15 Mn |
| Dec 31, 2022 | 29.02 Mn |
| Sep 30, 2022 | 45.81 Mn |
| Jun 30, 2022 | 41.61 Mn |
| Mar 31, 2022 | 82.92 Mn |
| Dec 31, 2021 | 50.76 Mn |
| Sep 30, 2021 | 54.09 Mn |
API Access
Coherus Oncology Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();